oxaliTEX

N/A

Report date: 2025/03/20 09:13:09
NME

Base Information

Drug NameoxaliTEX
Drug Alias Nameoxaliplatin-texaphyrin conjugate (University of Texas)oxaliplatin-texaphyrin conjugate (Cible)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeAustralia and New Zealand +[5] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas System
China Registration ClassN/A

Develop Information

Active CompaniesInnovoTEX IncOncoTEX Inc
Inactive CompaniesCible IncUniversity Of Texas System
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A